Login
$NHIV
$9.95 +$0.00 (0.0%) Close

Balance Sheets

In millions of USD, except per-share amounts
Jun 2026
As of Jun 30, 2026
Mar 2026
As of Mar 31, 2026
Assets:
Current assets
Cash and cash equivalents
Prepaid expenses
Due from Sponsor
Deferred offering costs
Total current assets
Investments held in trust account
Class A
Total investments held in trust account
Total Assets
Liabilities and Shareholders’ Deficit
Current liabilities
Related party loan
Accounts payable
Accrued offering costs
Accrued liabilities (including approximately $75,000 and $83,000, respectively, of offering costs at June 30, 2026 and December 31, 2025)
Deferred compensation
Total current liabilities
Deferred underwriting payable
Total liabilities
Class A ordinary shares subject to possible redemption, 20,125,000 and 0 shares, respectively, at June 30, 2026 and December 31, 2025, at redemption value of $10.06 per share at June 30, 2026
Shareholders’ Deficit
Ordinary shares, value
Additional paid-in capital
Accumulated deficit
Total Shareholders’ Deficit
Total Liabilities and Shareholders’ Deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support